The third party website you are linking to is not affiliated with accu-chek.com
Roche Diabetes Care, Inc. (“Roche”), the maker of Accu-Chek products, may have provided financial support to the company or organization to which you are about to link. Roche does not, however, have any control over the content provided on the third party website and the link to the third party website does not imply recommendation or endorsement by Roche.
The Accu-Chek Glucolytics Beta app is an innovative step forward in personalised diabetes care. The app collects and combines data from your supported wireless devices and data you enter. Artificial intelligence is applied to your data to make personal predictions about your future glucose levels. You’ll feel more confident before going to bed knowing your chance of having a nighttime hypo. And the app can show you how the meal you ate will affect your blood glucose trend for two hours afterwards. The Beta app can also reveal hidden high, low, and in-range patterns of glucose so that you can investigate the cause and act to resolve them.
Note: The Beta app offers the best experience for users who use multiple daily injections of insulin, for example, with an insulin pen. However, if you use an insulin pump, you can still use the app.
If you experience problems while testing the app, see the FAQ for more information about using the app and troubleshooting it.
If you have any questions, feel free to contact us at firstname.lastname@example.org
Accu-Chek Guide meter, Accu-Chek Mobile meter with wireless adapter, Eversense CGM, Pendiq Insulin Pen
Accu-Chek Guide, Accu-Chek Mobile meters with wireless adapter and Pendiq Insulin Pen communicate via Bluetooth® wireless technology. Eversensevia Cloud